The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Molecular mechanisms of T cell co-stimulation and co-inhibition
Open accessAbstract
Co-stimulatory and co-inhibitory receptors have a pivotal role in T cell biology, as they determine the functional outcome of T cell receptor (TCR) signalling. The classic definition of T cell co-stimulation continues to evolve through the identification of new co-stimulatory and co-inhibitory receptors, the biochemical characterization of their downstream signalling events and the delineation of their immunological functions. Notably, it has been recently appreciated that co-stimulatory and co-inhibitory receptors display great diversity in expression, structure and function, and that their functions are largely context dependent. Here, we focus on some of these emerging concepts and review the mechanisms through which T cell activation, differentiation and function is controlled by co-stimulatory and co-inhibitory receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Several genes, including C10orf54 (VISTA), LGALS9, and TNFRSF14, known to inhibit T cells (Benci et al., 2019, Chen and Flies, 2013) were broadly expressed.”
From Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma (2020) · cites this paper as Chen and Flies, 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Self-citationPD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Greenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,072
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860
Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,785
A Theory of Self-Nonself Discrimination
Bretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,755
CTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685
Combining immunotherapy and targeted therapies in cancer treatment
Vanneman, M. W., & Dranoff, G. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3237 · Cited by 1,627
Mueller, D. L., Jenkins, M. K., & Schwartz, R. H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002305 · Cited by 1,505
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Weiner, L. M., Surana, R., & Wang, S. (2010) · Nature reviews. Immunology · doi:10.1038/nri2744 · Cited by 1,339
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A. C., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,264
Yokosuka, T., Takamatsu, M., Kobayashi-Imanishi, W., Hashimoto-Tane, A., Azuma, M., & Saito, T. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112741 · Cited by 1,161
Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways
Fife, B. T., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00662.x · Cited by 1,081
Choi, Y. S., Kageyama, R., Eto, D. S., Escobar, T. C., Johnston, R. J., Monticelli, L. A., Lao, C., & Crotty, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.023 · Cited by 999
The role of TNF superfamily members in T-cell function and diseases
Croft, M. (2009) · Nature reviews. Immunology · doi:10.1038/nri2526 · Cited by 936
B70 antigen is a second ligand for CTLA-4 and CD28
Azuma, M., Ito, D., Yagita∥, H., Okumura, K., Phillips, J. H., Lanier, L. L., & Somoza, C. (1993) · Nature · doi:10.1038/366076a0 · Cited by 910
CD28 and CTLA-4 coreceptor expression and signal transduction
Rudd, C. E., Taylor, A., & Schneider, H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00770.x · Cited by 898
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Croft, M. (2003) · Nature reviews. Immunology · doi:10.1038/nri1148 · Cited by 863
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses
Walker, L. S. K., & Sansom, D. M. (2011) · Nature reviews. Immunology · doi:10.1038/nri3108 · Cited by 817
Sharma, M. D., Baban, B., Chandler, P., Hou, D., Singh, N., Yagita∥, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 791
Sheppard, K.-A., Fitz, L. J., Lee, J. M., Benander, C., George, J. A., Wooters, J., Qiu, Y., Jussif, J. M., Carter, L. L., Wood, C. R., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.083 · Cited by 791
PD-1 signaling in primary T cells
Riley, J. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00767.x · Cited by 778
T-cell co-stimulation through B7RP-1 and ICOS
Yoshinaga, S. K., Whoriskey, J. S., Khare, S. D., Sarmiento, U. M., Guo, J., Horan, T., Shih, G. C., Zhang, M., Coccia, M. A., Kohno, T., et al. (1999) · Nature · doi:10.1038/45582 · Cited by 772
T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
Linsley, P. S., Clark, E. A., & Ledbetter, J. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5031 · Cited by 749
Brandt, C. S., Baratin, M., Yi, E. C., Kennedy, J. J., Gao, Z., Fox, B. A., Haldeman, B. A., Ostrander, C. D., Kaifu, T., Chabannon, C., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090681 · Cited by 747
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
Wang, L. L., Rubinstein, R., Lines, J. L., Wasiuk, A., Ahonen, C. L., Guo, Y., Lu, L., Gondek, D. C., Wang, Y., Fava, R. A., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20100619 · Cited by 722
Larsen, C. P., Pearson, T. C., Adams, A. B., Tso, P. L., Shirasugi, N., Strobertb, E., Anderson, D., Cowan, S. R., Price, K., Naemura, J. R., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00749.x · Cited by 721
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
Hathcock, K. S., László, G., Pucillo, C. E. M., Linsley, P. S., & Hodes, R. J. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.2.631 · Cited by 670
Šedý, J. R., Gavrieli, M., Potter, K. G., Hurchla, M. A., Lindsley, R. C., Hildner, K., Scheu, S., Pfeffer, K., Ware, C. F., Murphy, T. L., et al. (2004) · Nature Immunology · doi:10.1038/ni1144 · Cited by 640
Inaba, K., Witmer-Pack, M. D., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita∥, H., Okumura, K., Linsley, P. S., Ikehara, S., et al. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.5.1849 · Cited by 593
June, C. H., Ledbetter, J. A., Gillespie, M., Lindsten, T., & Thompson, C. B. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.12.4472-4481.1987 · Cited by 565
Doering, T. A., Crawford, A., Angelosanto, J., Paley, M., Ziegler, C. G. K., & Wherry, E. J. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.021 · Cited by 560
B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
Azuma, T., Yao, S., Zhu, G., Flies, A. S., Flies, S. J., & Chen, L. (2008) · Blood · doi:10.1182/blood-2007-11-123141 · Cited by 555
Self-citationPatsoukis, N., Brown, J., Petkova, V., Liu, F., Li, L., & Boussiotis, V. A. (2012) · Science Signaling · doi:10.1126/scisignal.2002796 · Cited by 529
Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation
Hathcock, K. S., László, G., Dickler, H. B., Bradshaw, J., Linsley, P. S., & Hodes, R. J. (1993) · Science · doi:10.1126/science.7694361 · Cited by 517
SLAM Family Receptors and SAP Adaptors in Immunity
Cannons, J. L., Tangye, S. G., & Schwartzberg, P. L. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101302 · Cited by 502
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
Lin, D. Y.-W., Tanaka, Y., Iwasaki, M., Gittis, A. G., Su, H.-P., Mikami, B., Okazaki, T., Honjo, T., Minato, N., & Garboczi, D. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712278105 · Cited by 472
Munn, D. H., Sharma, M. D., & Mellor, A. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4100 · Cited by 469
The PDL1-PD1 Axis Converts Human T H 1 Cells into Regulatory T Cells
Amarnath, S., Mangus, C. W., Wang, J. C. M., Wei, F., He, A., Kapoor, V., Foley, J., Massey, P. R., Felizardo, T. C., Riley, J. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003130 · Cited by 463
Rangachari, M., Zhu, C., Sakuishi, K., Xiao, S., Karman, J., Chen, A., Angin, M., Wakeham, A., Greenfield, E. A., Sobel, R. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2871 · Cited by 394
Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.
Rudd, C. E., & Schneider, H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1131 · Cited by 392
Bcl6 and Maf Cooperate To Instruct Human Follicular Helper CD4 T Cell Differentiation
Kroenke, M. A., Eto, D. S., Locci, M., Cho, M., Davidson, T. M., Haddad, E. K., & Crotty, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103246 · Cited by 376
Bengsch, B., Seigel, B., Ruhl, M., Timm, J., Kuntz, M., Blum, H. E., Pircher, H., & Thimme, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000947 · Cited by 373
Fourcade, J., Sun, Z., Pagliano, O., Guillaume, P., Luescher, I. F., Sander, C., Kirkwood, J. M., Olive, D., Kuchroo, V., & Zarour, H. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2637 · Cited by 372
Goldberg, M. V., & Drake, C. G. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_114 · Cited by 337
B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
Park, J., Omiya, R., Matsumura, Y., Sakoda, Y., Kuramasu, A., Augustine, M. M., Yao, S., Tsushima, F., Narazaki, H., Anand, S., et al. (2010) · Blood · doi:10.1182/blood-2010-01-265975 · Cited by 331
Self-citationEngagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease
Paust, S., Lu, L., McCarty, N., & Cantor, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403342101 · Cited by 328
Franceschini, D., Paroli, M., Francavilla, V., Videtta, M., Morrone, S., Labbadia, G., Cerino, A., Mondelli, M. U., & Barnaba, V. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36604 · Cited by 316
The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T‐cell activation
Cai, G., & Freeman, G. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00783.x · Cited by 309
Nolte, M. A., van Olffen, R. W., van Gisbergen, K. P. J. M., & van Lier, R. A. W. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00774.x · Cited by 305
Eißner, G., Kölch, W., & Scheurich, P. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.011 · Cited by 303
Immune regulation by 4‐1BB and 4‐1BBL: complexities and challenges
Wang, C., Lin, G. H. Y., McPherson, A. J., & Watts, T. H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00765.x · Cited by 301
Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies
Ascierto, P. A., Simeone, E., Sznol, M., Fu, Y., & Melero, I. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.09.008 · Cited by 287
Angelosanto, J., Blackburn, S. D., Crawford, A., & Wherry, E. J. (2012) · Journal of Virology · doi:10.1128/jvi.00889-12 · Cited by 285
An Enigmatic Tail of CD28 Signaling
Boomer, J. S., & Green, J. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002436 · Cited by 283
Emerging Tim-3 functions in antimicrobial and tumor immunity
Sakuishi, K., Jayaraman, P., Behar, S. M., Anderson, A. C., & Kuchroo, V. K. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.003 · Cited by 270
Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS
Wang, S., Zhu, G., Chapoval, A. I., Dong, H., Tamada, K., Ni, J., & Chen, L. (2000) · Blood · doi:10.1182/blood.v96.8.2808 · Cited by 257
Self-citationChimeric antigen receptors for T cell immunotherapy: current understanding and future directions
Curran, K. J., Pegram, H. J., & Brentjens, R. J. (2012) · The Journal of Gene Medicine · doi:10.1002/jgm.2604 · Cited by 255
The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation
Steinberg, M. W., Cheung, T. C., & Ware, C. F. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01064.x · Cited by 252
Gonzalez, L. C., Loyet, K. M., Calemine-Fenaux, J., Chauhan, V., Wranik, B. J., Ouyang, W., & Eaton, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409071102 · Cited by 252
Flies, D. B., Wang, S., Xu, H., & Chen, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100660 · Cited by 249
Self-citationOX40 signaling favors the induction of TH9 cells and airway inflammation
Xiao, X., Balasubramanian, S., Liu, W., Chu, X., Wang, H., Taparowsky, E. J., Fu, Y., Choi, Y., Walsh, M. C., & Li, X. C. (2012) · Nature Immunology · doi:10.1038/ni.2390 · Cited by 243
Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)
Simpson, T. R., Quezada, S. A., & Allison, J. P. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.001 · Cited by 234
TNF superfamily in inflammatory disease: translating basic insights
Croft, M., Duan, W., Choi, H., Eun, S.-Y., Madireddi, S., & Mehta, A. K. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.10.004 · Cited by 232
Bour‐Jordan, H., & Bluestone, J. A. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00775.x · Cited by 229
SLAM receptors and SAP influence lymphocyte interactions, development and function
Schwartzberg, P. L., Mueller, K. L., Qi, H., & Cannons, J. L. (2008) · Nature reviews. Immunology · doi:10.1038/nri2456 · Cited by 226
Yokosuka, T., Kobayashi, W., Takamatsu, M., Sakata-Sogawa, K., Zeng, H., Hashimoto, A. S., Yagita∥, H., Tokunaga, M., & Saito, T. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.006 · Cited by 224
Hendriks, J., Xiao, Y., Rossen, J. W. A., van der Sluijs, K. F., Sugamura, K., Ishii, N., & Borst, J. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1665 · Cited by 212
Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2
Lázár‐Molnár, E., Yan, Q., Cao, E., Ramagopal, U. A., Nathenson, S. G., & Almo, S. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804453105 · Cited by 207
The Role of OX40-Mediated Co-stimulation in T-Cell Activation and Survival
Redmond, W. L., Ruby, C. E., & Weinberg, A. D. (2009) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v29.i3.10 · Cited by 205
Cell Surface Signaling Molecules in the Control of Immune Responses: A Tide Model
Zhu, Y., Yao, S., & Chen, L. (2011) · Immunity · doi:10.1016/j.immuni.2011.04.008 · Cited by 202
Self-citationThe Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo
Paterson, A. M., Brown, K. E., Keir, M. E., Vanguri, V. K., Riella, L. V., Chandraker, A. K., Sayegh, M. H., Blazar, B. R., Freeman, G. J., & Sharpe, A. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003496 · Cited by 198
Role of CD27/CD70 pathway of activation in immunity and tolerance
Denoeud, J., & Moser, M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0610351 · Cited by 197
Baitsch, L., Legat, A., Barba, L., Marraco, S. A. F., Rivals, J., Baumgaertner, P., Christiansen-Jucht, C., Bouzourène, H., Rimoldi, D., Pircher, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030852 · Cited by 196
Gavrieli, M., Watanabe, N., Loftin, S. K., Murphy, T. L., & MURPHY, K. M. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.070 · Cited by 193
Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
Bierer, B. E., Peterson, A. S., Gorga, J. C., Herrmann, S. H., & Burakoff, S. J. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.3.1145 · Cited by 169
Kageyama, R., Cannons, J. L., Zhao, F. R., Yusuf, I., Lao, C., Locci, M., Schwartzberg, P. L., & Crotty, S. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.016 · Cited by 167
The clinical utility of inhibiting CD28‐mediated costimulation
Linsley, P. S., & Nadler, S. G. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00780.x · Cited by 160
T-cell Clonal AnergyPreprint
Schwartz, R. H., Mueller, D. L., Jenkins, M. K., & Quill, H. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.072 · Cited by 159
GITR: A Modulator of Immune Response and Inflammation
Nocentini, G., & Riccardi, C. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_11 · Cited by 158
HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation
del Rio, M., Lucas, C. L., Bühler, L. H., Rayat, G. R., & Rodríguez-Barbosa, J.-I. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809590 · Cited by 157
B7-H2 Is a Costimulatory Ligand for CD28 in Human
Yao, S., Zhu, Y., Zhu, G., Augustine, M. M., Zheng, L., Goode, D. J., Broadwater, M., Ruff, W. E., Flies, S. J., Xu, H., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.014 · Cited by 153
Self-citationLinterman, M. A., Rigby, R. J., Wong, R. K., Silva, D., Withers, D. R., Anderson, G., Verma, N. K., Brink, R. A., Hutloff, A., Goodnow, C. C., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.015 · Cited by 152
Dong, Z., Davidson, D., Pérez‐Quintero, L., Kurosaki, T., Swat, W., & Veillette, A. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.023 · Cited by 145
HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria
Shui, J., Larangé, A., Kim, G., Vela, J. L., Zahner, S. P., Cheroutre, H., & Kronenberg, M. (2012) · Nature · doi:10.1038/nature11242 · Cited by 137
Opportunities and Challenges in the Development of Experimental Drug Combinations for Cancer
Humphrey, R. W., Brockway-Lunardi, L., Bonk, D., Dohoney, K. M., Doroshow, J. H., Meech, S. J., Ratain, M. J., Topalian, S. L., & Pardoll, D. M. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr246 · Cited by 135
ICOS Ligation Recruits the p50α PI3K Regulatory Subunit to the Immunological Synapse
Fos, C., Salles, A., Lang, V., Carrette, F., Audebert, S., Pastor, S., Ghiotto, M., Olive, D., Bismuth, G., & Nunès, J. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1969 · Cited by 132
Meylan, F., Richard, A. C., & Siegel, R. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01068.x · Cited by 132
Taylor, P. A., Lees, C. J., Fournier, S., Allison, J. P., Sharpe, A. H., & Blazar, B. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.34 · Cited by 130
Memory T cells need CD28 costimulation to remember
Boesteanu, A. C., & Katsikis, P. D. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.02.005 · Cited by 128
Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn
Bloch‐Queyrat, C., Fondanèche, M., Chen, R., Yin, L., Relouzat, F., Veillette, A., Fischer, A., & Latour, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050449 · Cited by 124
Zhao, F. R., Cannons, J. L., Dutta, M., Griffiths, G. M., & Schwartzberg, P. L. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.017 · Cited by 119
Chan, C. J., Andrews, D. M., & Smyth, M. J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.01.009 · Cited by 117
The CD4-like molecule LAG-3, biology and therapeutic applications
Sierro, S. R., Romero, P. J., & Speiser, D. E. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14712598.2011.540563 · Cited by 115
Takamura, S., Tsuji-Kawahara, S., Yagita∥, H., Akiba, H., Sakamoto, M., Chikaishi, T., Kato, M., & Miyazawa, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903478 · Cited by 105
New Insights on OX40 in the Control of T Cell Immunity and Immune Tolerance In Vivo
Xiao, X., Gong, W., Demirci, G., Liu, W., Spoerl, S., Chu, X., Bishop, D. K., Turka, L. A., & Li, X. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101373 · Cited by 102
Dynamic regulation of T cell activation and co‐stimulation through TCR‐microclusters
Saito, T., Yokosuka, T., & Hashimoto, A. S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.11.036 · Cited by 98
Sequence, structure, function, immunity: structural genomics of costimulation
Chattopadhyay, K., Lázár‐Molnár, E., Yan, Q., Rubinstein, R., Zhan, C., Vigdorovich, V. I., Ramagopal, U. A., Bonanno, J. B., Nathenson, S. G., & Almo, S. C. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00778.x · Cited by 95
Tao, R., Wang, L., MURPHY, K. M. M., Fraser, C. C., & Hancock, W. W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6649 · Cited by 94
Regulatory T Cells and Human Myeloid Dendritic Cells Promote Tolerance via Programmed Death Ligand-1
Amarnath, S., Costanzo, C. M., Mariotti, J., Ullman, J. L., Telford, W. G., Kapoor, V., Riley, J. L., Levine, B. L., June, C. H., Fong, T. C., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000302 · Cited by 92
Zhu, Y., Zhu, G., Luo, L., Flies, A. S., & Chen, L. (2007) · Blood · doi:10.1182/blood-2006-10-043463 · Cited by 89
Self-citationAssociation of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA
Gavrieli, M., & Murphy, K. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.036 · Cited by 85
Coordinate Regulation of T Cell Activation by CD2 and CD28
Green, J. M., Karpitskiy, V. V., Kimzey, S. L., & Shaw, A. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3591 · Cited by 84
Zeiser, R., Nguyen, V. H., Hou, J., Beilhack, A., Zambricki, E. A., Buess, M., Contag, C. H., & Negrin, R. S. (2006) · Blood · doi:10.1182/blood-2006-07-038455 · Cited by 78
T Cell Ig and Mucin Domain Proteins and Immunity
Kane, L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902937 · Cited by 76
Functional Exhaustion of CD4+ T Lymphocytes during Primary Cytomegalovirus Infection
Antoine, P., Olislagers, V., Huygens, A., Lecomte, S., Liesnard, C., Donner, C., & Marchant, A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101165 · Cited by 75
Wang, C., McPherson, A. J., Jones, R. B., Kawamura, K. S., Lin, G. H. Y., Lang, P. A., Ambagala, T., Pellegrini, M., Calzascia, T., Aidarus, N., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110675 · Cited by 73
Regulation of costimulation in the era of butyrophilins
Arnett, H. A., Escobar, S. M., & Viney, J. L. (2009) · Cytokine · doi:10.1016/j.cyto.2009.03.009 · Cited by 71
Sica, G., Zhu, G., Tamada, K., Liu, D., Ni, J., & Chen, L. (2001) · Blood · doi:10.1182/blood.v97.9.2702 · Cited by 71
Self-citationNegative feedback of T cell activation through inhibitory adapters and costimulatory receptors
Saito, T., & Yamasaki, S. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00022.x · Cited by 71
Harlin, H., Podack, E. R., Boothby, M. R., & Alegre, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2451 · Cited by 70
Bimodal regulation of T cell-mediated immune responses by TIM-4
Mizui, M., Shikina, T., Arase, H., Suzuki, K., Yasui, T., Rennert, P. D., Kumanogoh, A., & Kikutani, H. (2008) · International Immunology · doi:10.1093/intimm/dxn029 · Cited by 68
The Adaptor Protein TRADD Is Essential for TNF-Like Ligand 1A/Death Receptor 3 Signaling
Pobezinskaya, E. L., Choksi, S., Morgan, M. J., Cao, X., & Liu, Z.-G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002374 · Cited by 66
Transcription factor regulation of CD8+ T‐cell memory and exhaustion
Angelosanto, J., & Wherry, E. J. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00927.x · Cited by 56
Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway
Sakoda, Y., Park, J., Zhao, Y., Kuramasu, A., Geng, D., Liu, Y., Dávila, E., & Tamada, K. (2011) · Blood · doi:10.1182/blood-2010-08-301325 · Cited by 54
Differential Requirement of ZAP-70 for CD2-Mediated Activation Pathways of Mature Human T Cells
Meinl, E., Lengenfelder, D., Blank, N., Pirzer, R., Taborda‐Barata, L., & Hivroz, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3578 · Cited by 51
LAIR and collagens in immune regulation
Meyaard, L. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.09.014 · Cited by 48
Biochemical and Genetic Evidence for a SAP-PKC-θ Interaction Contributing to IL-4 Regulation
Cannons, J. L., Wu, J. Z., Gómez‐Rodríguez, J., Zhang, J., Dong, B., Liu, Y., Shaw, S., Siminovitch, K. A., & Schwartzberg, P. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902182 · Cited by 48
Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy
Liechtenstein, T., Dufait, I., Lanna, A., Breckpot, K., & Escors, D. (2012) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/187152212802001875 · Cited by 47
CD30—Governor of Memory T Cells?
Podack, E. R., Štrbo, N., SOTOSEC, V., & Muta, H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb05945.x · Cited by 45
An improved understanding of TNFL/TNFR interactions using structure-based classifications
Magis, C., van der Sloot, A. M., Serrano, L., & Notredame, C. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.06.002 · Cited by 34
Evidence Implicating the Ras Pathway in Multiple CD28 Costimulatory Functions in CD4+ T Cells
Janardhan, S. V., Praveen, K., Marks, R., & Gajewski, T. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024931 · Cited by 32
Knieke, K., Lingel, H., Chamaon, K., & Brunner-Weinzierl, M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031391 · Cited by 29
Cao, W., Ryan, M., Buckley, D. A., O’Connor, R., & Clarkson, M. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03424.x · Cited by 23
Xiao, L., Fu, Z., Liu, F., Zhang, L., Shi, X.-M., Shen, X., Ni, Z., Fu, H. Y., Li, R., Cao, X., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021697 · Cited by 12
Combined targeted and immunotherapy: the future of personalized medicine
Marabelle, A., & Caux, C. (2012) · Blood · doi:10.1182/blood-2012-09-455105 · Cited by 7
Letter: Cellular proliferation can be an unreliable index of immune competence.
Cunningham, A. J., & Lafferty, K. J. (1974) · PubMed · Cited by 6
Combating Chronic T-cell Exhaustion
McAfee, M. S., & Blattman, J. N. (2012) · Immunotherapy · doi:10.2217/imt.12.46 · Cited by 4
Research works printed but not linked: 1
- Lafferty, K. J. & Cunningham, A. J. A. New analysis of allogeneic interactions. J. Immunol. 112, 436–437 (1975). Lafferty and Cunningham extended the Bretscher and Cohn two-signal model to suggest that T cells require two signals for activation.
Cited by
Sorted by citations
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al. (2016) · Science · doi:10.1126/science.aad0501 · Cited by 4,944
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
Zhang, Y., & Zhang, Z. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,906
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Goodman, A. M., Kato, S., Bazhenova, L., Patel, S. P., Frampton, G. M., Miller, V., Stephens, P. J., Daniels, G. A., & Kurzrock, R. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0386 · Cited by 2,264
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
Metadata
- Authors
- Chen, L., & Flies, D. B.
- Affiliations
- Yale Cancer Center (US)
- University of New Mexico (US)
- Corresponding author
- Chen, Lieping
- Venue
- Nature Reviews Immunology
- Published
- 2013-03-08
- Volume
- 13
- Issue
- 4
- Pages
- 227-242
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC3786574
- OpenAlex
- W2130473166
- Cited by
- 3,114
- References
- 135
- Citations by year
- 2026: 148 · 2025: 258 · 2024: 259 · 2023: 276 · 2022: 305 · 2021: 312 · 2020: 310 · 2019: 250 · 2018: 275 · 2017: 238 · 2016: 195 · 2015: 148 · 2014: 101 · 2013: 35
- FWCI
- 13.52
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-06-05)
- Open access
- green
- europepmc.org
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Melanoma Research Alliance
- National Cancer Institute (CA 97085, CA 16359, CA121974, CA86721, R01CA097085, CA142779, R01CA085721, R01CA142779, P50CA121974, P30CA016359)
- National Institute of Allergy and Infectious Diseases (T32AI089704, R01AI072592, AI72592, T32AI007247)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- T cell costimulation, T cell co-inhibition, costimulatory receptors, co-inhibitory receptors, T cell receptor signaling, T cell activation, T cell differentiation, immune checkpoint molecules
- MeSH terms
- Humans, Lymphocyte Activation, Receptors, Antigen, T-Cell, T-Lymphocytes, Signal Transduction, CD28 Antigens, B7-1 Antigen, Models, Immunological, B7-2 Antigen, Receptors, Tumor Necrosis Factor, Member 14
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review